Cargando…
Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men
OBJECTIVE: To evaluate an epigenetic assay performed on tissue from negative prostate biopsies in a group of African American (AA) men undergoing repeat biopsy, and to compare accuracy for predicting repeat biopsy outcome to prior studies conducted in predominantly Caucasian populations. MATERIALS A...
Autores principales: | Waterhouse, Robert L., Van Neste, Leander, Moses, Kelvin A., Barnswell, Carlton, Silberstein, Jonathan L., Jalkut, Mark, Tutrone, Ronald, Sylora, James, Anglade, Ronald, Murdock, Myron, Shiffman, Zvi, Vandenberg, Todd, Shah, Nikhil, Carter, Michael, Krispin, Manuel, Groskopf, Jack, Van Criekinge, Wim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182891/ https://www.ncbi.nlm.nih.gov/pubmed/29660369 http://dx.doi.org/10.1016/j.urology.2018.04.001 |
Ejemplares similares
-
PubMeth: a cancer methylation database combining text-mining and expert annotation
por: Ongenaert, Maté, et al.
Publicado: (2008) -
Risk score predicts high‐grade prostate cancer in DNA‐methylation positive, histopathologically negative biopsies
por: Van Neste, Leander, et al.
Publicado: (2016) -
Cost-effectiveness of an urinary biomarker panel in combination with MRI for prostate cancer diagnosis
por: Govers, Tim M., et al.
Publicado: (2023) -
A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection
por: Van Neste, Leander, et al.
Publicado: (2012) -
Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia
por: Shore, Neal, et al.
Publicado: (2019)